IMPI
ALNY icon

Ilmarinen Mutual Pension Insurance’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ilmarinen Mutual Pension Insurance’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Hold
12,500
– – 0.03% 304
2026
Q1 		$4.14M Hold
12,500
– – 0.03% 296
2025
Q4 		$4.97M Sell
12,500
-8,500
-40% -$3.76M 0.04% 204
2025
Q3 		$9.58M Hold
21,000
– – 0.07% 135
2025
Q2 		$6.85M Buy
+21,000
New +$5.81M 0.06% 164

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ilmarinen Mutual Pension Insurance's ALNY Position: Q2 2026 in Review

Ilmarinen Mutual Pension Insurance held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 12,500 shares worth $3.76M. The position accounts for 0.03% of the portfolio, ranked #304.

Ilmarinen Mutual Pension Insurance first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.58M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Ilmarinen Mutual Pension Insurance held 12,500 shares of Alnylam Pharmaceuticals worth $3.76M as of Q2 2026.
  • Ilmarinen Mutual Pension Insurance left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.03% of Ilmarinen Mutual Pension Insurance's portfolio in Q2 2026, its #304 holding.
  • Ilmarinen Mutual Pension Insurance first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Ilmarinen Mutual Pension Insurance's Alnylam Pharmaceuticals position peaked at $9.58M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Ilmarinen Mutual Pension Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.